These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6798728)
21. Structural requirements for mitotane activity: development of analogs for treatment of adrenal cancer. Schteingart DE; Sinsheimer JE; Benitez RS; Homan DF; Johnson TD; Counsell RE Anticancer Res; 2012 Jul; 32(7):2711-20. PubMed ID: 22753730 [TBL] [Abstract][Full Text] [Related]
22. [Decrease in the intensity of the EPR cytochrome P-450, adrenodoxine and free radical signals in the adrenal cortex of dogs under the effect of o,p-dichlorodiphenyldichloroethane]. Mikosha AS; Berezovskaia NN Probl Endokrinol (Mosk); 1983; 29(5):62-5. PubMed ID: 6647432 [TBL] [Abstract][Full Text] [Related]
23. Fine structural and biochemical effects of aminoglutethimide and o,p'-DDD on rat adrenocortical carcinoma 494 and adrenals. Moore RN; Penney DP; Averill KT Anat Rec; 1980 Sep; 198(1):113-24. PubMed ID: 7457928 [TBL] [Abstract][Full Text] [Related]
24. Studies on the site of action of o,p'-DDD in the dog adrenal cortex. II. TPNH- and corticosteroid precursor-stimulation of o,p'-DDD inhibited steroidogenesis. Hart MM; Swackhamer ES; Straw JA Steroids; 1971 May; 17(5):575-86. PubMed ID: 4397309 [No Abstract] [Full Text] [Related]
25. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines. Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009 [TBL] [Abstract][Full Text] [Related]
26. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase. Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607 [TBL] [Abstract][Full Text] [Related]
27. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate. Haaparanta T; Halpert J; Glaumann H; Gustafsson JA Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054 [TBL] [Abstract][Full Text] [Related]
28. [Change in the urtrastructure of the dog adrenal cortex following short-term and prolonged administration of o, p'-DDD]. Gordienko VM; Kozyritskiĭ VG Arkh Anat Gistol Embriol; 1973 Jul; 65(7):90-5. PubMed ID: 4776429 [No Abstract] [Full Text] [Related]
29. Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers. Cai W; Benitez R; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL Biochem Pharmacol; 1995 May; 49(10):1483-9. PubMed ID: 7763292 [TBL] [Abstract][Full Text] [Related]
30. Effect of o,p'-DDD and Li+ on apoptotic DNA fragmentation in conventionally normal and tumour tissues of human adrenal cortex. Pushkarev VM; Tronko ND; Kostyuchenko NN; Mikosha AS Ukr Biokhim Zh (1999); 2007; 79(2):44-9. PubMed ID: 18030749 [TBL] [Abstract][Full Text] [Related]
31. In vitro bioactivation of the environmental pollutant 3-methylsulphonyl-2, 2-bis(4-chlorophenyl)-1,1-dichloroethene in the human adrenal gland. Jönsson CJ; Lund BO Toxicol Lett; 1994 Apr; 71(2):169-75. PubMed ID: 8171446 [TBL] [Abstract][Full Text] [Related]
32. Metabolism and covalent binding of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p,'-DDD). Correlation between adrenocorticolytic activity and metabolic activation by adrenocortical mitochondria. Martz F; Straw JA Drug Metab Dispos; 1980; 8(3):127-30. PubMed ID: 6104572 [No Abstract] [Full Text] [Related]
33. The organochlorine o,p'-DDD disrupts the adrenal steroidogenic signaling pathway in rainbow trout (Oncorhynchus mykiss). Lacroix M; Hontela A Toxicol Appl Pharmacol; 2003 Aug; 190(3):197-205. PubMed ID: 12902190 [TBL] [Abstract][Full Text] [Related]
34. [Effect of chloditan on the changes of activity of glutathione transferase, glutathione reductase and glutathione content in the adrenal glands and liver in rats]. Zorich PA; Tronko ND; Mikosha AS Fiziol Zh (1994); 1994; 40(1):86-90. PubMed ID: 7713231 [TBL] [Abstract][Full Text] [Related]
35. Metabolism of 1-(0-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p'-DDD) in rats. Reif VD; Sinsheimer JE Drug Metab Dispos; 1975; 3(1):15-25. PubMed ID: 234830 [TBL] [Abstract][Full Text] [Related]
36. Metabolic activation and binding of mitotane in adrenal cortex homogenates. Cai W; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL J Pharm Sci; 1995 Feb; 84(2):134-8. PubMed ID: 7738789 [TBL] [Abstract][Full Text] [Related]
37. [Transport of electrons from mitochondria to microsomes in the reconstituted system of cell organelles]. Chistiakov VV; Pospelova LN Biokhimiia; 1982 Jan; 47(1):55-61. PubMed ID: 6802189 [TBL] [Abstract][Full Text] [Related]
38. [Corticosteroid synthesis in chicken adrenals as affected by o,p'-DDD]. Kravchenko VI Ukr Biokhim Zh (1978); 1978; 50(2):180-3. PubMed ID: 307291 [TBL] [Abstract][Full Text] [Related]
39. [Cytochromes c and P-450 as terminal acceptors in a reconstituted system of mitochondrial hydroxylation]. Armenian AG; Mardanian SS; Nalbandian RM Biokhimiia; 1982 May; 47(5):784-90. PubMed ID: 6284260 [TBL] [Abstract][Full Text] [Related]
40. Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer. Lindhe O; Skogseid B Horm Metab Res; 2010 Sep; 42(10):725-30. PubMed ID: 20665429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]